Mangold Insight Investor Breakfast

Mar 24, 2021

Cyxone is making progress on our groundbreaking early-stage treatments for Rheumatoid Arthritis, Multiple Sclerosis and Covid-19. On 7 April, 2021 between 10.20 and 10.40 CEO Tara Heitner will present the latest updates at the online event Mangold Insight Investor Breakfast.

Follow the presentation live at And to reach out to our CEO to find out more about investing, partnering or for more information, contact her at